Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Double-blind placebo-controlled study of oxatomide in the treatment of childhood asthma.

Double-blind placebo-controlled study of oxatomide in the treatment of childhood asthma. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Double-blind placebo-controlled study of oxatomide in the treatment of childhood asthma. Abstract Text:

    c p chiuC P Chiu,j l huangJ L Huang,t y linT Y Lin,w b shiehW B Shieh,k h hsiehK H Hsieh,

    Oxatomide is an orally active H1-histamine receptor antagonist. It has been demonstrated to have therapeutic efficacy in the treatment of allergic diseases in adults. The aim of this study was to evaluate the efficacy and safety of oxatomide in the treatment of asthma in children. Sixty-four asthmatic children of both sexes, aged between 5 and 16 years, were enrolled in this double-blind, placebo-controlled trial with a duration of 4 months. Patients were randomized chosen to receive either oxatomide with a daily dose of 1 to 2 mg/kg body weight or a placebo twice daily. Clinical evaluations including pulmonary function tests and immunological studies. The patients' impression on the effect of treatment also were recorded during the study. The effects of bronchodilatation and normalizing pulmonary function were observed 2 months after oxatomide treatment. The levels of eosinophil cationic protein and total asthma symptom scores were significantly reduced during treatment with oxatomide. There was no significant change in total IgE or IgG4 before or after treatment in either the treatment or control groups. During the study, two (5.8%) oxatomide treated patients reported slight drowsiness and one (2.9%) reported body weight gain. Routine laboratory tests showed no significant alterations. In conclusion, oxatomide was generally well tolerated in this study and may have the potential of being an effective treatment for childhood asthma.

    Double-blind placebo-controlled study of oxatomide in the treatment of childhood asthma. Publishing Authors By Initials

    cp chiuCP Chiu,jl huangJL Huang,ty linTY Lin,wb shiehWB Shieh,kh hsiehKH Hsieh,

    For similar heterocyclic compounds: heterocyclic compounds, 1-ring: piperazines research abstracts see: heterocyclic compounds: heterocyclic compounds, 1-ring: piperazines research

    PUBMED ID PMID:

    MEDLINE DATE:

    Double-blind placebo-controlled study of oxatomide in the treatment of childhood asthma. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Zhonghua Minguo xiao er ke yi xue hui za zhi [Jour

    VOLUME: 38

    Page Numbers: 14-20

    Journal Abbreviation:

    ISSN: 0001-6578

    DAY: 12

    MONTH: 02

    YEAR: 2008

    Double-blind placebo-controlled study of oxatomide in the treatment of childhood asthma. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 16210470

    Double-blind placebo-controlled study of oxatomide in the treatment of childhood asthma. Keywords Mesh Terms:

    KEYWORDS: Piperazines

    MESH TERMS: therapeutic use

    Chemical & Substance for Abstract: Double-blind placebo-controlled study of oxatomide in the treatment of childhood asthma. Information

    Substance Name: oxatomide

    Registry Number: 60607-34-3

    Grant and Affiliation Information for Double-blind placebo-controlled study of oxatomide in the treatment of childhood asthma.

    AFFILIATION: Department of Pediatrics, Chang Gung Children's Hospital, Linko, Taiwan, R.O.C.

    Country: TAIWAN

    TAIWAN Research PublicationTAIWAN Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Zhonghua Min Guo Xiao Er Ke Yi

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Double-blind placebo-controlled study of oxatomide in the treatment of childhood asthma Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News